Indian J Med Sci About us | Subscription  |  Top cited articles | Contact Us | Feedback | Login   
Print this page Email this page   Small font size Default font size Increase font size 
 Users Online : 48
Home Current Issue Ahead of print Back Issues  Instructions Search e-Alerts
  Navigate here 
  Search
 
 ¤  Next article
 ¤  Previous article 
 ¤  Table of Contents
  
 Resource links
 ¤   Similar in PUBMED
 ¤   [PDF Not available] *
 ¤   Citation Manager
 ¤   Access Statistics
 ¤   Reader Comments
 ¤   Email Alert *
 ¤   Add to My List *
* Registration required (free)  


  In this article

 Article Access Statistics
    Viewed911    
    Printed48    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 


 
PRACTITIONERS SECTION
Year : 2000  |  Volume : 54  |  Issue : 4  |  Page : 151-153
 

The cephelosporins



Correspondence Address:
Login to access the Email id


PMID: 11227126

Get Permissions



How to cite this article:
. The cephelosporins. Indian J Med Sci 2000;54:151-3

How to cite this URL:
. The cephelosporins. Indian J Med Sci [serial online] 2000 [cited 2013 May 20];54:151-3. Available from: http://www.indianjmedsci.org/text.asp?2000/54/4/151/12134


The cephelosporins are antibio­tics similar to penicillin derived from fungus. In Sardinia Prof Bottzu cultured this fungus from sewage fall identified as capholos­porim acremonium. The fungus was further investigated by Harvard Flowery and he found that the fungus produced not one but seve­ral antibiotics.

The cephelosporins are board spectrum.B lactum antibacterial antibiotics. They were introduced in 1960 in clinical practice. Since then they are widely used as com­pared to previously used antibio­tics because of low toxicity and favourable broad spectrum activity Pharmacokinetics. Now a days they are used as first line agents in the treatment of many infections i.e. pneumonia, meningitis and gonorrhea.

Cephelosporins bears close re­semblance in the composition of penicillins. They are water salable and stable to change in pH, and temperature. Various cephelos­porins differ in their antibacterial spectrum and their resistant to betalactum.

Cephelosporins act by inhibiting bacterial cell wall synthesis in a manner similar to penicillins and are bactericidal. Resistance to cephelosporins develop slowly. Cross resistance for other beta lactum agents also occurs.

Cephelosporins are administer­ed orally or by intravenous route. lntramuscular injections are pain­ful. Their body distribution is simi­lar to penicillins. The concentra­tion in eye and C.S.F. is poor. There are differences in pharma­cokinetics amongst various cep­helisporins. They are eliminated mainly by kidney and high concen­tration is achieved in urinary tract. Exceretion is reduced in cases of renal insufficiency and in case of renal function impairment, the dose of cephelosporins should be re­duced. Adverse reactions are oc­casional allergy, skin rash, fever, serum sickness and anaphylactic should not be used in those who reactions (rare). Cephelosporins have history of reaction to peni­cillin.

Food and antacids reduced ab­sorption of the orally administered cephelosporins but some of the newer ones are readily absorbed with food. They all penetrate well into most tissues and all compart­ments Orally given cephelosporins do not achieve high concentration in C.S.F. Orally they are to be given three or four times a day. Most parenterally administered cephelo­sphorins have relatively short half life (0.5 to 2 hrs.) and thus require administering every 6 to 8 hours. The dosage vary with the prepara­tion and generation of cephelo­sporins and are available from the manufacturers.

Cephelosporins are quite often first line of treatment in many in­fections including pneumonia, meningitis. New cephelosporins are introduced frequently, each one has a unique spectrum of acti­vity or advantage over previously available drugs.

The various cephelosphorins are usually classified into generation based on the development and also loosely on their spectrum of activity. They are available in both oral and parental form.

Fourth generation cephelospho­rin was introduced in 1997. Cafe-pine is new one with properties Like third generation but most resistant to some beta lactums. It is used parenterally .

Spectrum of activity and clinical indications cephelosphorins have broad spectrums and low toxicity. They are good choice for initial empirical treatment of many infec­tious diseases. They are easy to administer. They are effective for treatment of many conditions in­cluding pneumonia, skin and soft tissue infections and meningitis. The differences amongst nume­rous cephelosphorins are subtle, however an understanding of these differences is essential for optimal use of them. As a result of wide spread use of cephelosphorins bacterial resistance to these drugs are increasingly common. They are not effective against enterolocci (strap faccalis) and against ana­erobic infections. Except for caphataxime, cephtriaxone, coffa­zidine and ceftiaxime CNS pene­tration is poor. These four drugs are useful from gram negative bacillary meningitis.

Cephelosphorins are commonly used in pneumonia and when it be­come complication of sedentary life and some of noso comial in­fections. They are used in menin­gitis and is considered a drug of choice. Penicillin resistant gono­cocci is commonly susceptible to cepholosphorins. They have been used in preoperative antimicrobial prophylaxis. They have been used in endocarditis. Cephelosphorins are in use for more three decades and have been used in treatment of many infections. Choosing a proper cephelosphorin is a difficult task. It depends upon understand­ing of its activity, toxicity and cost. It should not be used where other cheaper and effective antibiotics are available. The advent of new fourth generation of cephelosphorin will prolong their utility. To in­crease their usefulness and to prevent drug resistance other ef­fective antibiotics should be used in combination. E. B.




 

Top
Print this article  Email this article
Previous article Next article

    

© 2004 - Indian Journal of Medical Sciences
Published by Medknow
Online since 15th December '04